These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 25190225)
21. Chitosan-based mucoadhesive films loaded with curcumin for topical treatment of oral cancer. Tolentino S; Cardoso CO; Monteiro MM; Taveira SF; Gratieri T; Cunha-Filho M; Guerra ENS; Gelfuso GM Int J Biol Macromol; 2024 Oct; 278(Pt 3):134887. PubMed ID: 39168194 [TBL] [Abstract][Full Text] [Related]
22. In vitro evaluation of the cytotoxic and mutagenic potential of the 5-aminolevulinic acid hexylester-mediated photodynamic therapy. Zenzen V; Zankl H Mutat Res; 2004 Jul; 561(1-2):91-100. PubMed ID: 15238234 [TBL] [Abstract][Full Text] [Related]
23. 5-aminolevulinic acid-incorporated nanoparticles of methoxy poly(ethylene glycol)-chitosan copolymer for photodynamic therapy. Chung CW; Chung KD; Jeong YI; Kang DH Int J Nanomedicine; 2013; 8():809-19. PubMed ID: 23589688 [TBL] [Abstract][Full Text] [Related]
24. Assessment of sequential combination of 5-fluorouracil-loaded-chitosan-nanoparticles and ALA-photodynamic therapy on HeLa cell line. Benito-Miguel M; Blanco MD; Gómez C Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):466-75. PubMed ID: 25976508 [TBL] [Abstract][Full Text] [Related]
25. Photodynamic Therapy of oral dysplasia with topical 5-aminolevulinic acid and light-emitting diode array. Tsai JC; Chiang CP; Chen HM; Huang SB; Wang CW; Lee MI; Hsu YC; Chen CT; Tsai T Lasers Surg Med; 2004; 34(1):18-24. PubMed ID: 14755421 [TBL] [Abstract][Full Text] [Related]
26. Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Chen HM; Chen CT; Yang H; Kuo MY; Kuo YS; Lan WH; Wang YP; Tsai T; Chiang CP Oral Oncol; 2004 Jul; 40(6):630-7. PubMed ID: 15063392 [TBL] [Abstract][Full Text] [Related]
27. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222 [TBL] [Abstract][Full Text] [Related]
28. Topical photodynamic therapy is very effective for oral verrucous hyperplasia and oral erythroleukoplakia. Lin HP; Chen HM; Yu CH; Yang H; Wang YP; Chiang CP J Oral Pathol Med; 2010 Sep; 39(8):624-30. PubMed ID: 21054548 [TBL] [Abstract][Full Text] [Related]
29. miR-145 mediates the anti-cancer stemness effect of photodynamic therapy with 5-aminolevulinic acid (ALA) in oral cancer cells. Fang CY; Chen PY; Ho DC; Tsai LL; Hsieh PL; Lu MY; Yu CC; Yu CH J Formos Med Assoc; 2018 Aug; 117(8):738-742. PubMed ID: 29936107 [TBL] [Abstract][Full Text] [Related]
30. Co-delivery of chitosan nanoparticles of 5-aminolevulinic acid and shGBAS for improving photodynamic therapy efficacy in oral squamous cell carcinomas. Wang X; Li S; Liu H Photodiagnosis Photodyn Ther; 2021 Jun; 34():102218. PubMed ID: 33592329 [TBL] [Abstract][Full Text] [Related]
31. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study. Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080 [TBL] [Abstract][Full Text] [Related]
32. Enhancing the effect of 5-aminolevulinic acid based photodynamic therapy in human meningioma cells. Cornelius JF; Slotty PJ; El Khatib M; Giannakis A; Senger B; Steiger HJ Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):1-6. PubMed ID: 24486853 [TBL] [Abstract][Full Text] [Related]
33. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy. de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825 [TBL] [Abstract][Full Text] [Related]
34. Development and in vitro evaluation of buccal mucoadhesive films for photodynamic inactivation of Candida albicans. Vecchi CF; Said Dos Santos R; Bassi da Silva J; Rosseto HC; Sakita KM; Svidzinski TIE; Bonfim-Mendonça PS; Bruschi ML Photodiagnosis Photodyn Ther; 2020 Dec; 32():101957. PubMed ID: 32818649 [TBL] [Abstract][Full Text] [Related]
35. Unidirectional drug release from 3D printed mucoadhesive buccal films using FDM technology: In vitro and ex vivo evaluation. Eleftheriadis GK; Ritzoulis C; Bouropoulos N; Tzetzis D; Andreadis DA; Boetker J; Rantanen J; Fatouros DG Eur J Pharm Biopharm; 2019 Nov; 144():180-192. PubMed ID: 31550525 [TBL] [Abstract][Full Text] [Related]
36. Mucoadhesive films containing chitosan-coated nanoparticles: a new strategy for buccal curcumin release. Mazzarino L; Borsali R; Lemos-Senna E J Pharm Sci; 2014 Nov; 103(11):3764-3771. PubMed ID: 25187001 [TBL] [Abstract][Full Text] [Related]
37. Chitosan-tripolyphosphate nanoparticles-mediated co-delivery of MTHFD1L shRNA and 5-aminolevulinic acid for combination photodynamic-gene therapy in oral cancer. Wang J; Wang K; Liang J; Jin J; Wang X; Yan S Photodiagnosis Photodyn Ther; 2021 Dec; 36():102581. PubMed ID: 34648994 [TBL] [Abstract][Full Text] [Related]
38. Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid. Calzavara-Pinton PG; Venturini M; Capezzera R; Sala R; Zane C Photodermatol Photoimmunol Photomed; 2004 Jun; 20(3):144-7. PubMed ID: 15144392 [TBL] [Abstract][Full Text] [Related]
39. Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy. Ishizuka M; Abe F; Sano Y; Takahashi K; Inoue K; Nakajima M; Kohda T; Komatsu N; Ogura S; Tanaka T Int Immunopharmacol; 2011 Mar; 11(3):358-65. PubMed ID: 21144919 [TBL] [Abstract][Full Text] [Related]
40. 5-aminolevulinic acid induce apoptosis via NF-κB/JNK pathway in human oral cancer Ca9-22 cells. Chen HM; Liu CM; Yang H; Chou HY; Chiang CP; Kuo MY J Oral Pathol Med; 2011 Jul; 40(6):483-9. PubMed ID: 21138480 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]